Brief: Olix Pharmaceuticals Subsidiary Mcurex Announces Agreements To Advance Development Of MRNA Vaccines And Therapeutics
07/06/2021 13:58
June 7 (Reuters) - OliX Pharmaceuticals Inc 226950.KQ :
* OLIX PHARMACEUTICALS SUBSIDIARY MCUREX ANNOUNCES BUSINESS
AGREEMENTS TO ADVANCE DEVELOPMENT OF MRNA VACCINES AND
THERAPEUTICS
* OLIX PHARMACEUTICALS INC - MCUREX HAS SIGNED MEMORANDUMS
OF
UNDERSTANDING WITH SAMYANG HOLDINGS
* OLIX PHARMACEUTICALS INC - UNDER AGREEMENT WITH SAMYANG
HOLDINGS, COMPANIES WILL DEVELOP AN MRNA VACCINE FOR COVID-19
* OLIX PHARMACEUTICALS INC - IN COLLABORATION WITH GC
PHARMA,
MCUREX WILL RESEARCH AND DEVELOP MRNA VACCINES AND TREATMENTS
FOR RESPIRATORY INFECTIONS
Source text for Eikon: ID:nGNXcTt4b
Further company coverage: 226950.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug
Brief: OliX Pharmaceuticals Administers First Patient In Phase 1 Clinical Study of Androgenic Alopecia Treatment